Category Archives: Biochemistry

Biochemistry

Join Michael Behe for an Online Conversation about Viruses and Evolution – Discovery Institute

In a free online Zoom webinar on Saturday, June 13, biochemist Behe will review the biochemistry of viruses in general and COVID-19 in particular. He will use these topical examples to illustrate a fundamental principle: Darwinian and other unintelligent evolutionary mechanisms can change life marginally, in ways that are medically important, yet they cannot explain lifes complex structure. Rather, the elegant molecular structures of life required purposeful intelligent design.

Join us from 6 pm to 7:30 pm. Registration is required! Find more information and a link to register here. The event is graciously sponsored by the Colorado, Houston, and Southern California ChaptersofDiscovery Institutes Science & Culture Network.

Photo credit: Michael Behe, by Chris Morgan.

See the article here:
Join Michael Behe for an Online Conversation about Viruses and Evolution - Discovery Institute

Biochemistry

NIH Award Supports Research on Biological Drug to Rebuild Heart Tissue – University of Arkansas Newswire

University of Arkansas

Josh Sakon, University of Arkansas

FAYETTEVILLE, Ark. With funding from the National Institutes of Health, University of Arkansas researchers hope to develop the first therapeutic drug that can regenerate heart tissue. The lesion-seeking biological drug, released through stent placement, could treat coronary blockages and prevent heart failure.

Currently, there are no viable therapeutics available on the market that can promote regeneration of the heart to prevent myocardial infarction, or heart attack, said Josh Sakon, professor of biochemistry in the J. William Fulbright College of Arts and Sciences. All available medicines treat only symptoms to slow the onset of heart failure. The design of our biologics improves current methods of controlled release, because it takes advantage of specific biochemical events that occur during heart failure.

Biologics, or biological drugs, are pharmaceutical products made from or containing components of living organisms. Used in biotechnology, biologics include a variety of products taken from humans, animals or microorganisms.

Sakon received $30,000 from the NIH and a matching gift from the Commercialization Fund, a subset of the U of A Chancellors Fund to develop and commercialize sFGF1, a human fibroblast growth factor designed by Suresh Thallapuranam, professor of biochemistry. Fibroblast growth factors are cell-signaling proteins involved in a variety of processes critical to normal physiological development. Irregularities in the function of these proteins lead to a range of developmental defects.

Thallapuranam and Kartik Balachandran, associate professor of biomedical engineering, are part of Sakons team focused on developing the drug. They are working on fusing sFGF1 with a different, collagen-binding protein released through stents, the thin mesh tubes that a heart surgeon inserts into arteries and blood vessels to relieve blockage and promote tissue healing. As Sakon mentioned, the advantage of their drug is that it functions in accordance with specific biochemical activity that occurs leading up to and during an adverse event.

In addition to funding drug development, the NIH award will help the researchers obtain intellectual property and pursue critical safety and feasibility assessments, including toxicity and biocompatibility testing in both lab and animal studies. Their results will be used to secure Small Business Technology Transfer funding for preclinical efficacy studies before seeking approval from the U.S. Food and Drug Administration. The NIH funding will also help the researchers identify a potential drug carrier.

The researchers project is one of seven biomedical innovations funded by the NIH via XLerateHealth and its affiliate, the Southeast XLerator Network, which is led by the University of Kentucky. The award is part of the networks Ideas to Products program that supports researchers with competitive proof-of-concept funding that will help accelerate healthcare technologies for commercialization.

With 24 academic institutions, the Southeast XLerator Network was created to support the commercialization of promising life science and healthcare innovation in several southeastern states and Puerto Rico. Its program goal is to broaden the geographic distribution of NIH funding and to help accelerate early-stage biomedical technology from laboratory to market, with an emphasis on supporting geographically underserved areas in healthcare.

According to the American Heart Association, more than 600,000 Americans experience a new myocardial infarction each year, with 275,000 deaths attributable to heart failure. About one in four patients who survive an initial heart attack develop heart failure within four years of the initial first heart attack. Rapid diagnosis and intervention after a coronary blockage can significantly improve chances of patient survival.

Suresh Thallapuranam holds the Cooper Chair of Bioinformatics Research.

About the University of Arkansas: The University of Arkansas provides an internationally competitive education for undergraduate and graduate students in more than 200 academic programs. The university contributes new knowledge, economic development, basic and applied research, and creative activity while also providing service to academic and professional disciplines. The Carnegie Foundation classifies the University of Arkansas among fewer than 3 percent of colleges and universities in America that have the highest level of research activity. U.S. News & World Report ranks the University of Arkansas among its top American public research universities. Founded in 1871, the University of Arkansas comprises 10 colleges and schools and maintains a low student-to-faculty ratio that promotes personal attention and close mentoring.

Original post:
NIH Award Supports Research on Biological Drug to Rebuild Heart Tissue - University of Arkansas Newswire

Biochemistry

Automatic Biochemistry Analyzers Market Research Report 2020: Key Players, Applications, Drivers, Trends and Forecast to 2026 – WaterCloud News

Prefectural Hospital

In addition, the report categorizes product type and end uses as dynamic market segments that directly impact the growth potential and roadmap of the target market. The report highlights the core developments that are common to all regional hubs and their subsequent impact on the holistic growth path of the Automatic Biochemistry Analyzers market worldwide. Other valuable aspects of the report are the market development history, various marketing channels, supplier analysis, potential buyers and the analysis of the markets industrial chain.

Ask For Discounts @ https://www.marketresearchintellect.com/ask-for-discount/?rid=254034&utm_source=WCS&utm_medium=888

Table of Content

1 Introduction of Automatic Biochemistry Analyzers Market

1.1 Overview of the Market1.2 Scope of Report1.3 Assumptions

2 Executive Summary

3 Research Methodology of Verified Market Research

3.1 Data Mining3.2 Validation3.3 Primary Interviews3.4 List of Data Sources

4 Automatic Biochemistry Analyzers Market Outlook

4.1 Overview4.2 Market Dynamics4.2.1 Drivers4.2.2 Restraints4.2.3 Opportunities4.3 Porters Five Force Model4.4 Value Chain Analysis

5 Automatic Biochemistry Analyzers Market, By Deployment Model

5.1 Overview

6 Automatic Biochemistry Analyzers Market, By Solution

6.1 Overview

7 Automatic Biochemistry Analyzers Market, By Vertical

7.1 Overview

8 Automatic Biochemistry Analyzers Market, By Geography

8.1 Overview8.2 North America8.2.1 U.S.8.2.2 Canada8.2.3 Mexico8.3 Europe8.3.1 Germany8.3.2 U.K.8.3.3 France8.3.4 Rest of Europe8.4 Asia Pacific8.4.1 China8.4.2 Japan8.4.3 India8.4.4 Rest of Asia Pacific8.5 Rest of the World8.5.1 Latin America8.5.2 Middle East

9 Automatic Biochemistry Analyzers Market Competitive Landscape

9.1 Overview9.2 Company Market Ranking9.3 Key Development Strategies

10 Company Profiles

10.1.1 Overview10.1.2 Financial Performance10.1.3 Product Outlook10.1.4 Key Developments

11 Appendix

11.1 Related Research

Customized Research Report Using Corporate Email Id @ https://www.marketresearchintellect.com/need-customization/?rid=254034&utm_source=WCS&utm_medium=888

About Us:

Market Research Intellect provides syndicated and customized research reports to clients from various industries and organizations with the aim of delivering functional expertise. We provide reports for all industries including Energy, Technology, Manufacturing and Construction, Chemicals and Materials, Food and Beverage and more. These reports deliver an in-depth study of the market with industry analysis, market value for regions and countries and trends that are pertinent to the industry.

Contact Us:

Mr. Steven Fernandes

Market Research Intellect

New Jersey ( USA )

Tel: +1-650-781-4080

Tags: Automatic Biochemistry Analyzers Market Size, Automatic Biochemistry Analyzers Market Trends, Automatic Biochemistry Analyzers Market Growth, Automatic Biochemistry Analyzers Market Forecast, Automatic Biochemistry Analyzers Market Analysis Sarkari result, Government Jobs, Sarkari naukri, NMK, Majhi Naukri,

See the rest here:
Automatic Biochemistry Analyzers Market Research Report 2020: Key Players, Applications, Drivers, Trends and Forecast to 2026 - WaterCloud News

Biochemistry

Fort Bend ISD Class of 2020 valedictorians, salutatorians – Chron.com

Austin High School valedictorian Joshua Cheung is planning to attend the University of Texas at Austin to study mechanical engineering. His advice: Try your best. Remember what is most important to you and avoid losing sight of your goals. Dont take life too seriously and remember to have fun!

Austin High School valedictorian Joshua Cheung is planning to attend the University of Texas at Austin to study mechanical engineering. His advice: Try your best. Remember what is most important to you and

Photo: Courtesy Fort Bend ISD

Austin High School valedictorian Joshua Cheung is planning to attend the University of Texas at Austin to study mechanical engineering. His advice: Try your best. Remember what is most important to you and avoid losing sight of your goals. Dont take life too seriously and remember to have fun!

Austin High School valedictorian Joshua Cheung is planning to attend the University of Texas at Austin to study mechanical engineering. His advice: Try your best. Remember what is most important to you and

Fort Bend ISD Class of 2020 valedictorians, salutatorians

Fort Bend ISD recently announced the top two students for each of the districts 11 high school Class of 2020 graduates.Fort Bend County Judge KP George, who served as district trustee before winning election as county judge, urged students to continue striving for excellence.

Congratulations to our future leaders, Judge George said in a telephone interview Friday. I encourage you to strive higher and work harder, so you can achieve your hopes and dreams to build a better future for all. We need you more than ever.

Related: New venue, different dates announced for Fort Bend ISD graduations due to COVID-19

Austin High School

Valedictorian Joshua Cheung is planning to attend the University of Texas at Austin to study mechanical engineering. His advice: Try your best. Remember what is most important to you and avoid losing sight of your goals. Dont take life too seriously and remember to have fun! Salutatorian Naveen Ali is planning to attend the University of Texas at Austin to study computer science. His advice: Life is a collection of failures. The people that succeed are those who learn from these failures.

Bush High School

Valedictorian Evan He is planning to attend the University of Texas at Austin to study biomedical engineering with plans to later to start a company that solves the antibiotic resistance crisis from the worlds over-reliance on antibiotics. His advice: Never lose an opportunity because you doubted yourself. Living life without regrets means committing wholeheartedly to the most challenging decisions. If you never test the boundaries of your limits, you will never be able to reach your full potential. Salutatorian Jada Dan Nguyen is planning to attend the University of Texas at Austin to study biology and public health and go on to graduate from medical school and become a cardiologist. Her advice: Be prepared to adapt and learn to take experiences as lessons, a sign, or motivation.

Clements High School

Valedictorian Siddharth Muppalla is a National Merit Scholar who is planning to study mathematics and computer science at Massachusetts Institute of Technology to pursue a career in finance. His advice: Reality is built by your beliefs. Salutatorian Stephan Xie plans to study computer science and philosophy at Rice University. His advice: Be fearless leaders and fight for solutions to the world we now handle.

Dulles High School

Valedictorian Shaan Parekh is a National Merit Scholar who aspires to become an entrepreneur and is planning to attend the University of Texas at Austin to study computer science and business. His advice: Do more, and then some. Salutatorian Krish Singal plans to attend the University of Texas at Austin to study computer science and mathematics as a Turing Scholar and aspires to innovate, discover and build a better tomorrow with the power of science. His advice: Live life with a mission and savor the adventure.

Elkins High School

Valedictorian Kaitlyn Nguyen plans to attend the University of California at Los Angeles to study biochemistry and aspires to graduate from medical school and become a doctor. Her advice: Take chances, make mistakes, and get messy! Salutatorian Jesica Joy plans to study biochemistry at the University of Texas at Austin with a goal of graduating from medical school and working in emergency medicine. Her advice: Work hard and never lose sight of what inspires and excites you. Find what youre passionate about and follow it.

Hightower High School

Valedictorian Isabella Gandara is a National Merit Scholar who plans to study biological engineering and computer science at the Massachusetts Institute of Technology to eventually pursue scientific research as a principal investigator in the field of computational biology. Her advice: Look to other people for inspiration, but never try to imitate their success. Your life, your happiness, and your success should be uniquely your own. Salutatorian Snehal Anil Kumar is planning to study biochemistry at the University of Texas at Austin with her goal to attend medical school. Her advice: Strive to be a lighthouse to the despairing ship captains of the world.

Kempner High School

Valedictorian Emily Nguyen plans to study biological sciences at Rice University and hopes to graduate from medical school and become a doctor. Her advice: We have but one life. Lets live it well and do some good along the way. Salutatorian Trish Nguyen-Thach plans to study biology at the University of Houston with the goal of becoming a dentist with a possible specialization in specialize in orthodontics or prosthodontics. Her advice: With patience and persistence, we can achieve anything. We are the future and the change.

Marshall High School

Valedictorian Christian Wilson plans to study arts and entertainment tech at the University of Texas and hopes to work in the entertainment sector as a director, screen writer, animator or working for Disney. His advice: Do not be stressed about the little things in life because if you are, you will not be able to enjoy the big things that are going to happen. Just handle your business and have fun while doing so. Salutatorian Mija Obey is planning to study forensic chemistry at Sam Houston State University. Her goal is to become a Forensic Scientist in more than one department and find my purpose in life:. Her advice: A smooth sea never made a skilled sailor- Franklin D. Roosevelt

Ridge Point High School

Valedictorian John Breinholt IV will study chemistry at the University of Utah with further plans to study orthopedic surgery for the spine at the University of Arizona Medical School. Advice: Successful careers take more than just skill or intelligence. You will hardly get anywhere with a bad attitude towards others. Salutatorian Meredith Stickler is planning to study business at the University of Texas at Austin and hopes to graduate from law school. Her advice: Set goals to push yourself. Pain is temporary, but quitting is forever.

Travis High School

Valedictorian Sahana Ramaswamy will study biomedical engineering at Texas A&M University with post-college plans to work in a research position and aid in the development of biomedical technology. Advice: Your efforts always matter. You may not see the results today or tomorrow, but success will undoubtedly be in your future. Never give up. Salutatorian Amy Li plans to study design at the University of Texas and become a creative director or an industrial designer. Advice: Believe in yourself and be curious.

Willowridge High School

Valedictorian Alexander Vazquez-Benitez will study biomedical engineering at the University of Texas at Austin and aspires to become a biomedical engineer. Advice: Be sure to learn from your mistakes, persevere and be open to change. Salutatorian Neida Murillo plans to study biochemistry at Texas A&M University and hopes to become a perfusionist. Advice: You are capable of a lot, which you have proven by graduating amid a difficult time. Remember to hide from the procrastination monster.

Graduation ceremonies are scheduled June 1-6 at Kenneth Hall Stadium.

knix@hcnonline.com

See more here:
Fort Bend ISD Class of 2020 valedictorians, salutatorians - Chron.com

Biochemistry

Mynomx Pioneers the Personalization Science of Food Nutrition to Prevent and Fight Onset of COVID-19 – Yahoo Finance

Mynomx Inc. (formerly Precision Wellness, Inc.), a Silicon Valley-based company at the intersection of next-generation AI analytics and the latest medical and nutrition science, today announced their personalized nutrition approach to boosting cardio and metabolic health for disease prevention and immune system support.

The Novel Coronavirus (COVID-19) has swept the world and struck those with underlying cardiometabolic syndrome: inflammation, hypertension, obesity, diabetes, and cardiovascular disorders, the hardest. The incidence and prevalence of people with cardiometabolic syndromes are on the rise, with over 40% of the US population suffering from one form of cardiovascular disease, posing the greatest burden as the nation's costliest chronic disease and number one killer.

It is clear a new approach to prevention is needed and one that involves proper nutritional interventions. Mynomx focuses on preventing the onset and progression of cardiovascular and metabolic disorders, using food as medicine, through an AI-driven personalized nutrition approach designed to each person's unique metabolism, biochemistry, health, and genetics.

"Expression of our genetic blueprint works hand-in-hand with our nutritional consumption to define our metabolism. The food that we eat directly affects the biochemical pathways that may result in a metabolic imbalance within every tissue and cell, including those of our immune system", explains Dr. Mehrdad Rezaee, Interventional Cardiologist at Cardiac and Vascular Care, a clinical scientist and a Mynomx co-founder.

The Mynomx personalized nutrition approach is predicated on AI health predictive and food recommendation engines designed from the ground up to improve balance across those cardio and metabolic pillars of health that prevent the onset of inflammation, hypertension, obesity, dyslipidemia, and diabetes.

According to Dr. Rezaee, "Achieving metabolic balance leads to an efficient metabolism which is associated with increased energy levels, optimal weight, and a bolstered immune system that can remove toxins, fight bacteria and viruses, and help in preventing the onset and severity of disease, as well as the recovery from injuries."

Unlike other food platforms that only score the quality of food without the knowledge of a person's true state of health, Mynomx's personalized nutrition platform connects food, nutrition, and health at the molecular level to provide precision nutrition food scoring and recommendations based on a person's unique biology and health.

Each person's unique health and biochemistry requires different nutrients, restrictions, and sensitivities that define their personalized dietary pattern. Mynomx combines this pattern with an individual's preference, to produce a curated list of foods ranked based on this precision nutrition score.

"We believe we can profoundly improve the health of our communities through actionable health insights and recommendations that use food-as-medicine personalized to bolster each person's metabolic response," explains Mynomx CEO Nazhin Zarghamee.

Mynomx AI applies this food scoring to whole foods, meals, packaged foods, restaurants, and recipes, to allow for healthy choices at the point of food shopping, meal selection, and meal planning decision making. Food retailers can use the Mynomx platform to build deeper personalization and engagement applications.

Mynomx's outcome-driven approach is predicated around nutritional guidelines and patterns designed to boost metabolic functioning and fight COVID-19. Government and self-insured organizations can use Mynomx predictive analytics to understand the at-risk population and deliver personalized nutrition programs to drive population health, ensuring the health of our communities.

Mynomx health predictions (previously Precision Wellness) have been validated with the highest levels of accuracy across 2.8M patient populations in conjunction with leading institutions such as Stanford Medicine [or University] & Broad Institute (a Harvard, MIT, Massachusetts General Hospital Collaborative). Reference Publication.

About Mynomx

Mynomx is a leading scientific food personalization company that offers organizations and individuals an advanced, integrative approach to managing their health through personalized health insights and nutritional intervention. The data-driven Mynomx analytic platform, powered by the latest in nutritional science at the molecular level, multi-omics, and next-generation AI, offers the means to manage health through "food as medicine," preventing disease and supporting healthy aging. In addition to serving individuals, our platform is ideal for insurance and self-insured organization, corporate wellness, testing, and diagnostic companies as well as food retailers who are seeking deeper personalization and engagement. To learn more, visit http://www.mynomx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200529005651/en/

Contacts

Stu Smithmedia@mynomx.com

See the original post here:
Mynomx Pioneers the Personalization Science of Food Nutrition to Prevent and Fight Onset of COVID-19 - Yahoo Finance

Biochemistry

CCRC researchers focusing on COVID-19 – University of Georgia

UGAs Complex Carbohydrate Research Center is tackling the pandemic

Within weeks of the appearance of COVID-19, five teams of researchers at the University of Georgias Complex Carbohydrate Research Center put other research work aside to understand the virus, how it gets into our cells, and the changes that occur inside infected cells.

This work could help identify patients most at risk early, identify ways to slow down the disease, understand which drugs provide some hope to fight it, and perhaps, in a more distant future, to even develop vaccines for viruses before a disease spreads in humans.

With COVID-19, like other diseases, a key part of understanding the disease is understanding the role played by branching structures of sugars called complex carbohydrates or glycans.

There is no human disease that doesnt in some way involve carbohydrates, said Michael Tiemeyer, Distinguished Research Professor and co-director of the CCRC.

And no center in the world brings together as many world-renowned carbohydrate researchers as CCRC, which this year is celebrating 35 years of being a leader in glycoscience, or the study of complex carbohydrates.

CCRC faculty member and GRA Distinguished Investigator Lance Wells and other UGA collaborators are working to study the virus and its coating of carbohydrates that affect COVID-19s ability to bind to a host.

Rob Woods, professor of biochemistry and molecular biology, and his collaborators are applying 3D computational models they had created to study influenza to understand the novel coronavirus. Their models analyze the position of glycans on the viruss surface that help it evade the hosts immune system.

When a virus tries to infect a cell, it first encounters a wall of glycans that covers the cell. Geert-Jan Boons, UGA Foundation Distinguished Professor in Biochemical Sciences, studies how viruses find a way through this carbohydrate forest. His lab creates complex carbohydrates, like the ones that surround human cells, to test whether viruses can bind to them or not. For the COVID-19 research they are focusing on a class of carbohydrate that they already had successfully produced.

Carbohydrates also play a role in how the COVID-19 infection progresses.

The problem my team and I are trying to answer is how to know who should go into the hospital and who shouldnt, Tiemeyer said. Just knowing how much virus someone has isnt enough, because severity doesnt necessarily correlate with viral load. His collaborators, respiratory biologists at the University of North Carolina, discovered that COVID-19 targets glands in the airway.

It is not only glands that the disease affects. The metabolism of any infected cell will change, too, and traces of these changes can be found in the blood.

The starting point for Art Edisons group is comparing blood samples from ferret models. Edisons expertise lies in identifying small molecules in the blood called metabolitesbasically any small molecule in our bodies, in our food, or produced by our cells, such as cholesterol and vitaminsusing CCRCs specialized facilities.

Edison also stressed that, if collaboration and knowledge sharing are a key part of what the CCRC does, they matter now more than ever.

In this project, more than in any other in my career, we want to make measurements that will make a difference and share our data as soon as it is collected and we know its any good, he said. It is not the time for personal territory or trying to be the first at publishing.

Read the full story.

Continue reading here:
CCRC researchers focusing on COVID-19 - University of Georgia

Biochemistry

New genomic method helps obtain high-resolution maps of DNA in the cell nucleus – News-Medical.net

Researchers at Karolinska Institutet in Sweden have developed a new sequencing method that makes it possible to map how DNA is spatially organized in the cell nucleus - revealing which genomic regions are at higher risk of mutation and DNA damage.

The technique is described in an article published in the scientific journal Nature Biotechnology.

Most cells in the human body contain approximately two metres of DNA. This long stretch of DNA is divided in 46 large pieces - the chromosomes - which occupy discrete regions of the cell nucleus known as chromosome territories.

How individual parts of the genome are spatially arranged in the nucleus strongly affects how they are being read by the cell's transcriptional apparatus. However, the spatial arrangement of individual genes in the three-dimensional (3D) space of the nucleus has remained largely unexplored.

Now, a team of researchers led by Dr. Magda Bienko at Science for Life Laboratory (SciLifeLab) and the Department of Medical Biochemistry and Biophysics at Karolinska Institutet has developed a new genomic method, named Genomic loci Positioning by Sequencing or GPSeq, which can be used to obtain high-resolution maps of how DNA is spatially organized in the cell nucleus.

The method works by gradually cutting the DNA from the nuclear periphery towards the centre, followed by reading the DNA sequence around each cut. Mathematical modelling can then be used to reconstruct the 3D genome structure and find where individual genes and regions between genes are located along the nuclear radius as well as in relation to each other.

We found that the spatial distribution of different types of chromatin (composed of DNA, RNA and protein complexes) often differed from what we expected to find.

Dr Magda Bienko, Senior Author, Science for Life Laboratory, Department of Medical Biochemistry, Karolinska Institutet

"To our surprise, we found that the picture is not as simple as having all the inactive chromatin sitting at the nuclear periphery and the active chromatin amassed in the centre.

Instead, there is a continuum, a gradient of increasing activity from the nuclear periphery towards the interior, even though the inactive chromatin can be found in the very centre of the nucleus too."

An important aspect of knowing where different genomic regions are located in the nucleus is that it is now possible to map where DNA damage and mutations are most likely to occur, explains Dr. Nicola Crosetto, a senior researcher at the same department at Karolinska Institutet and the other senior author of the paper.

"We discovered that DNA mutations that are often encountered in different cancer types are enriched in the inactive chromatin located at the nuclear periphery, which might have to do with the fact that many mutagens originate from outside the cell," he says.

"On the other hand, DNA breaks and gene fusions are much more likely to be found in the nuclear centre, which might be due to the high levels of transcription that we find in the centre."

Source:

Journal reference:

Girelli, G., et al. (2020) GPSeq reveals the radial organization of chromatin in the cell nucleus. Nature Biotechnology. doi.org/10.1038/s41587-020-0519-y.

The rest is here:
New genomic method helps obtain high-resolution maps of DNA in the cell nucleus - News-Medical.net

Biochemistry

Medical Grade Chitosan Market Recent Trends and Developments, by Type, by Product, Regional growth, Profit Margin, Market size, Revenue and Sales over…

In-depth Report On Medical Grade Chitosan Market including Market Landscape, and Market size, Revenues by players, Revenues by regions.

The global Medical Grade Chitosan market is broadly analyzed in this report that sheds light on critical aspects such as the vendor landscape, competitive strategies, market dynamics, and regional analysis. The report helps readers to clearly understand the current and future status of the global Medical Grade Chitosan market. The research study comes out as a compilation of useful guidelines for players to secure a position of strength in the global market. The authors of the report profile leading companies of the global Medical Grade Chitosan market, Also the details about important activities of leading players in the competitive landscape.

Some of the Important Key player operating in the Report are: Primex, KitoZyme, BIO21, YSK, Vietnam Food, NovaMatrix, KIMICA, Ningbo Zhenhai Haixin Biological, Golden-Shell Pharmaceutical, Zhejiang Fengrun Biotech, Jiangsu Shuanglin, Jiangsu Aoxin Biotechnology, Qingdao Yunzhou Biochemistry

Get PDF Sample Copy of the Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) :

https://www.qyresearch.com/sample-form/form/1544436/global-medical-grade-chitosan-market

The report predicts the size of the global Medical Grade Chitosan market in terms of value and volume for the forecast period 2020-2026. As per the analysis provided in the report, the global Medical Grade Chitosan market is expected to rise at a CAGR of xx % between 2020 and 2026 to reach a valuation of US$ xx million/billion by the end of 2026. In 2020, the global Medical Grade Chitosan market attained a valuation of US$ XX million/billion. The market researchers deeply analyze the global Medical Grade Chitosan industry landscape and the future prospects it is anticipated to create

Segmental Analysis

The report has classified the global Medical Grade Chitosan industry into segments including product type and application. Every segment is evaluated based on growth rate and share. Besides, the analysts have studied the potential regions that may prove rewarding for the Medical Grade Chitosan manufacturers in the coming years. The regional analysis includes reliable predictions on value and volume, thereby helping market players to gain deep insights into the overall Medical Grade Chitosan industry.

Global Medical Grade Chitosan Market Segment By Type:

Animal Origin Chitosan, Plant Based Chitosan

Global Medical Grade Chitosan Market Segment By Application:

Chitosan (CS) is a linear polysaccharide which is achieved by deacetylation of chitin, which is the second most plentiful compound in nature, after cellulose. Chitosan was applied in pharmaceutics/drug/gene delivery and cell encapsulation. Chitosan was applied in binding to protein drugs, contact lenses and implants. GMP grade chitosan covers chitosan for a variety of medical applications. The industrys leading producers are Primex, KitoZyme and BIO21, with a combined revenue share of 29.72% in 2019. In 2019, the

Competitive Landscape

It is important for every market participant to be familiar with the competitive scenario in the global Medical Grade Chitosan industry. In order to fulfill the requirements, the industry analysts have evaluated the strategic activities of the competitors to help the key players strengthen their foothold in the market and increase their competitiveness.

Key companies operating in the global Medical Grade Chitosan market include: Primex, KitoZyme, BIO21, YSK, Vietnam Food, NovaMatrix, KIMICA, Ningbo Zhenhai Haixin Biological, Golden-Shell Pharmaceutical, Zhejiang Fengrun Biotech, Jiangsu Shuanglin, Jiangsu Aoxin Biotechnology, Qingdao Yunzhou Biochemistry

Key questions answered in the report:

Enquire for Customization in the Report:https://www.qyresearch.com/customize-request/form/1544436/global-medical-grade-chitosan-market

Table of Contents

1 Medical Grade Chitosan Market Overview1.1 Medical Grade Chitosan Product Overview1.2 Medical Grade Chitosan Market Segment by Type1.2.1 Animal Origin Chitosan1.2.2 Plant Based Chitosan1.3 Global Medical Grade Chitosan Market Size by Type (2015-2026)1.3.1 Global Medical Grade Chitosan Market Size Overview by Type (2015-2026)1.3.2 Global Medical Grade Chitosan Historic Market Size Review by Type (2015-2020)1.3.2.1 Global Medical Grade Chitosan Sales Market Share Breakdown by Type (2015-2026)1.3.2.2 Global Medical Grade Chitosan Revenue Market Share Breakdown by Type (2015-2026)1.3.2.3 Global Medical Grade Chitosan Average Selling Price (ASP) by Type (2015-2026)1.3.3 Global Medical Grade Chitosan Market Size Forecast by Type (2021-2026)1.3.3.1 Global Medical Grade Chitosan Sales Market Share Breakdown by Application (2021-2026)1.3.3.2 Global Medical Grade Chitosan Revenue Market Share Breakdown by Application (2021-2026)1.3.3.3 Global Medical Grade Chitosan Average Selling Price (ASP) by Application (2021-2026)1.4 Key Regions Market Size Segment by Type (2015-2020)1.4.1 North America Medical Grade Chitosan Sales Breakdown by Type (2015-2026)1.4.2 Europe Medical Grade Chitosan Sales Breakdown by Type (2015-2026)1.4.3 Asia-Pacific Medical Grade Chitosan Sales Breakdown by Type (2015-2026)1.4.4 Latin America Medical Grade Chitosan Sales Breakdown by Type (2015-2026)1.4.5 Middle East and Africa Medical Grade Chitosan Sales Breakdown by Type (2015-2026)1.5 Coronavirus Disease 2019 (Covid-19): Medical Grade Chitosan Industry Impact1.5.1 How the Covid-19 is Affecting the Medical Grade Chitosan Industry1.5.1.1 Medical Grade Chitosan Business Impact Assessment Covid-191.5.1.2 Supply Chain Challenges1.5.1.3 COVID-19s Impact On Crude Oil and Refined Products1.5.2 Market Trends and Medical Grade Chitosan Potential Opportunities in the COVID-19 Landscape1.5.3 Measures / Proposal against Covid-191.5.3.1 Government Measures to Combat Covid-19 Impact1.5.3.2 Proposal for Medical Grade Chitosan Players to Combat Covid-19 Impact 2 Global Medical Grade Chitosan Market Competition by Company2.1 Global Top Players by Medical Grade Chitosan Sales (2015-2020)2.2 Global Top Players by Medical Grade Chitosan Revenue (2015-2020)2.3 Global Top Players Medical Grade Chitosan Average Selling Price (ASP) (2015-2020)2.4 Global Top Manufacturers Medical Grade Chitosan Manufacturing Base Distribution, Sales Area, Product Type2.5 Medical Grade Chitosan Market Competitive Situation and Trends2.5.1 Medical Grade Chitosan Market Concentration Rate (2015-2020)2.5.2 Global 5 and 10 Largest Manufacturers by Medical Grade Chitosan Sales and Revenue in 20192.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Medical Grade Chitosan as of 2019)2.7 Date of Key Manufacturers Enter into Medical Grade Chitosan Market2.8 Key Manufacturers Medical Grade Chitosan Product Offered2.9 Mergers & Acquisitions, Expansion 3 Global Medical Grade Chitosan Status and Outlook by Region (2015-2026)3.1 Global Medical Grade Chitosan Market Size and CAGR by Region: 2015 VS 2020 VS 20263.2 Global Medical Grade Chitosan Market Size Market Share by Region (2015-2020)3.2.1 Global Medical Grade Chitosan Sales Market Share by Region (2015-2020)3.2.2 Global Medical Grade Chitosan Revenue Market Share by Region (2015-2020)3.2.3 Global Medical Grade Chitosan Sales, Revenue, Price and Gross Margin (2015-2020)3.3 Global Medical Grade Chitosan Market Size Market Share by Region (2021-2026)3.3.1 Global Medical Grade Chitosan Sales Market Share by Region (2021-2026)3.3.2 Global Medical Grade Chitosan Revenue Market Share by Region (2021-2026)3.3.3 Global Medical Grade Chitosan Sales, Revenue, Price and Gross Margin (2021-2026)3.4 North America Medical Grade Chitosan Market Size YoY Growth (2015-2026)3.4.1 North America Medical Grade Chitosan Revenue YoY Growth (2015-2026)3.4.2 North America Medical Grade Chitosan Sales YoY Growth (2015-2026)3.5 Asia-Pacific Medical Grade Chitosan Market Size YoY Growth (2015-2026)3.5.1 Asia-Pacific Medical Grade Chitosan Revenue YoY Growth (2015-2026)3.5.2 Asia-Pacific Medical Grade Chitosan Sales YoY Growth (2015-2026)3.6 Europe Medical Grade Chitosan Market Size YoY Growth (2015-2026)3.6.1 Europe Medical Grade Chitosan Revenue YoY Growth (2015-2026)3.6.2 Europe Medical Grade Chitosan Sales YoY Growth (2015-2026)3.7 Latin America Medical Grade Chitosan Market Size YoY Growth (2015-2026)3.7.1 Latin America Medical Grade Chitosan Revenue YoY Growth (2015-2026)3.7.2 Latin America Medical Grade Chitosan Sales YoY Growth (2015-2026)3.8 Middle East and Africa Medical Grade Chitosan Market Size YoY Growth (2015-2026)3.8.1 Middle East and Africa Medical Grade Chitosan Revenue YoY Growth (2015-2026)3.8.2 Middle East and Africa Medical Grade Chitosan Sales YoY Growth (2015-2026) 4 Global Medical Grade Chitosan by Application4.1 Medical Grade Chitosan Segment by Application4.1.1 Wound Care4.1.2 Healthcare Products4.1.3 Antibacterial Products4.1.4 Others4.2 Global Medical Grade Chitosan Sales by Application: 2015 VS 2020 VS 20264.3 Global Medical Grade Chitosan Historic Sales by Application (2015-2020)4.4 Global Medical Grade Chitosan Forecasted Sales by Application (2021-2026)4.5 Key Regions Medical Grade Chitosan Market Size by Application4.5.1 North America Medical Grade Chitosan by Application4.5.2 Europe Medical Grade Chitosan by Application4.5.3 Asia-Pacific Medical Grade Chitosan by Application4.5.4 Latin America Medical Grade Chitosan by Application4.5.5 Middle East and Africa Medical Grade Chitosan by Application 5 North America Medical Grade Chitosan Market Size by Country (2015-2026)5.1 North America Market Size Market Share by Country (2015-2020)5.1.1 North America Medical Grade Chitosan Sales Market Share by Country (2015-2020)5.1.2 North America Medical Grade Chitosan Revenue Market Share by Country (2015-2020)5.2 North America Market Size Market Share by Country (2021-2026)5.2.1 North America Medical Grade Chitosan Sales Market Share by Country (2021-2026)5.2.2 North America Medical Grade Chitosan Revenue Market Share by Country (2021-2026)5.3 North America Market Size YoY Growth by Country5.3.1 U.S. Medical Grade Chitosan Market Size YoY Growth (2015-2026)5.3.2 Canada Medical Grade Chitosan Market Size YoY Growth (2015-2026) 6 Europe Medical Grade Chitosan Market Size by Country (2015-2026)6.1 Europe Market Size Market Share by Country (2015-2020)6.1.1 Europe Medical Grade Chitosan Sales Market Share by Country (2015-2020)6.1.2 Europe Medical Grade Chitosan Revenue Market Share by Country (2015-2020)6.2 Europe Market Size Market Share by Country (2021-2026)6.2.1 Europe Medical Grade Chitosan Sales Market Share by Country (2021-2026)6.2.2 Europe Medical Grade Chitosan Revenue Market Share by Country (2021-2026)6.3 Europe Market Size YoY Growth by Country6.3.1 Germany Medical Grade Chitosan Market Size YoY Growth (2015-2026)6.3.2 France Medical Grade Chitosan Market Size YoY Growth (2015-2026)6.3.3 U.K. Medical Grade Chitosan Market Size YoY Growth (2015-2026)6.3.4 Italy Medical Grade Chitosan Market Size YoY Growth (2015-2026)6.3.5 Russia Medical Grade Chitosan Market Size YoY Growth (2015-2026) 7 Asia-Pacific Medical Grade Chitosan Market Size by Country (2015-2026)7.1 Asia-Pacific Market Size Market Share by Country (2015-2020)7.1.1 Asia-Pacific Medical Grade Chitosan Sales Market Share by Country (2015-2020)7.1.2 Asia-Pacific Medical Grade Chitosan Revenue Market Share by Country (2015-2020)7.2 Asia-Pacific Market Size Market Share by Country (2021-2026)7.2.1 Asia-Pacific Medical Grade Chitosan Sales Market Share by Country (2021-2026)7.2.2 Asia-Pacific Medical Grade Chitosan Revenue Market Share by Country (2021-2026)7.3 Asia-Pacific Market Size YoY Growth by Country7.3.1 China Medical Grade Chitosan Market Size YoY Growth (2015-2026)7.3.2 Japan Medical Grade Chitosan Market Size YoY Growth (2015-2026)7.3.3 South Korea Medical Grade Chitosan Market Size YoY Growth (2015-2026)7.3.4 India Medical Grade Chitosan Market Size YoY Growth (2015-2026)7.3.5 Australia Medical Grade Chitosan Market Size YoY Growth (2015-2026)7.3.6 Taiwan Medical Grade Chitosan Market Size YoY Growth (2015-2026)7.3.7 Indonesia Medical Grade Chitosan Market Size YoY Growth (2015-2026)7.3.8 Thailand Medical Grade Chitosan Market Size YoY Growth (2015-2026)7.3.9 Malaysia Medical Grade Chitosan Market Size YoY Growth (2015-2026)7.3.10 Philippines Medical Grade Chitosan Market Size YoY Growth (2015-2026)7.3.11 Vietnam Medical Grade Chitosan Market Size YoY Growth (2015-2026) 8 Latin America Medical Grade Chitosan Market Size by Country (2015-2026)8.1 Latin America Market Size Market Share by Country (2015-2020)8.1.1 Latin America Medical Grade Chitosan Sales Market Share by Country (2015-2020)8.1.2 Latin America Medical Grade Chitosan Revenue Market Share by Country (2015-2020)8.2 Latin America Market Size Market Share by Country (2021-2026)8.2.1 Latin America Medical Grade Chitosan Sales Market Share by Country (2021-2026)8.2.2 Latin America Medical Grade Chitosan Revenue Market Share by Country (2021-2026)8.3 Latin America Market Size YoY Growth by Country8.3.1 Mexico Medical Grade Chitosan Market Size YoY Growth (2015-2026)8.3.2 Brazil Medical Grade Chitosan Market Size YoY Growth (2015-2026)8.3.3 Argentina Medical Grade Chitosan Market Size YoY Growth (2015-2026) 9 Middle East and Africa Medical Grade Chitosan Market Size by Country (2015-2026)9.1 Middle East and Africa Market Size Market Share by Country (2015-2020)9.1.1 Middle East and Africa Medical Grade Chitosan Sales Market Share by Country (2015-2020)9.1.2 Middle East and Africa Medical Grade Chitosan Revenue Market Share by Country (2015-2020)9.2 Middle East and Africa Market Size Market Share by Country (2021-2026)9.2.1 Middle East and Africa Medical Grade Chitosan Sales Market Share by Country (2021-2026)9.2.2 Middle East and Africa Medical Grade Chitosan Revenue Market Share by Country (2021-2026)9.3 Middle East and Africa Market Size YoY Growth by Country9.3.1 Turkey Medical Grade Chitosan Market Size YoY Growth (2015-2026)9.3.2 Saudi Arabia Medical Grade Chitosan Market Size YoY Growth (2015-2026)9.3.3 UAE Medical Grade Chitosan Market Size YoY Growth (2015-2026) 10 Company Profiles and Key Figures in Medical Grade Chitosan Business10.1 Primex10.1.1 Primex Corporation Information10.1.2 Primex Description, Business Overview and Total Revenue10.1.3 Primex Medical Grade Chitosan Sales, Revenue and Gross Margin (2015-2020)10.1.4 Primex Medical Grade Chitosan Products Offered10.1.5 Primex Recent Development10.2 KitoZyme10.2.1 KitoZyme Corporation Information10.2.2 KitoZyme Description, Business Overview and Total Revenue10.2.3 KitoZyme Medical Grade Chitosan Sales, Revenue and Gross Margin (2015-2020)10.2.4 Primex Medical Grade Chitosan Products Offered10.2.5 KitoZyme Recent Development10.3 BIO2110.3.1 BIO21 Corporation Information10.3.2 BIO21 Description, Business Overview and Total Revenue10.3.3 BIO21 Medical Grade Chitosan Sales, Revenue and Gross Margin (2015-2020)10.3.4 BIO21 Medical Grade Chitosan Products Offered10.3.5 BIO21 Recent Development10.4 YSK10.4.1 YSK Corporation Information10.4.2 YSK Description, Business Overview and Total Revenue10.4.3 YSK Medical Grade Chitosan Sales, Revenue and Gross Margin (2015-2020)10.4.4 YSK Medical Grade Chitosan Products Offered10.4.5 YSK Recent Development10.5 Vietnam Food10.5.1 Vietnam Food Corporation Information10.5.2 Vietnam Food Description, Business Overview and Total Revenue10.5.3 Vietnam Food Medical Grade Chitosan Sales, Revenue and Gross Margin (2015-2020)10.5.4 Vietnam Food Medical Grade Chitosan Products Offered10.5.5 Vietnam Food Recent Development10.6 NovaMatrix10.6.1 NovaMatrix Corporation Information10.6.2 NovaMatrix Description, Business Overview and Total Revenue10.6.3 NovaMatrix Medical Grade Chitosan Sales, Revenue and Gross Margin (2015-2020)10.6.4 NovaMatrix Medical Grade Chitosan Products Offered10.6.5 NovaMatrix Recent Development10.7 KIMICA10.7.1 KIMICA Corporation Information10.7.2 KIMICA Description, Business Overview and Total Revenue10.7.3 KIMICA Medical Grade Chitosan Sales, Revenue and Gross Margin (2015-2020)10.7.4 KIMICA Medical Grade Chitosan Products Offered10.7.5 KIMICA Recent Development10.8 Ningbo Zhenhai Haixin Biological10.8.1 Ningbo Zhenhai Haixin Biological Corporation Information10.8.2 Ningbo Zhenhai Haixin Biological Description, Business Overview and Total Revenue10.8.3 Ningbo Zhenhai Haixin Biological Medical Grade Chitosan Sales, Revenue and Gross Margin (2015-2020)10.8.4 Ningbo Zhenhai Haixin Biological Medical Grade Chitosan Products Offered10.8.5 Ningbo Zhenhai Haixin Biological Recent Development10.9 Golden-Shell Pharmaceutical10.9.1 Golden-Shell Pharmaceutical Corporation Information10.9.2 Golden-Shell Pharmaceutical Description, Business Overview and Total Revenue10.9.3 Golden-Shell Pharmaceutical Medical Grade Chitosan Sales, Revenue and Gross Margin (2015-2020)10.9.4 Golden-Shell Pharmaceutical Medical Grade Chitosan Products Offered10.9.5 Golden-Shell Pharmaceutical Recent Development10.10 Zhejiang Fengrun Biotech10.10.1 Company Basic Information, Manufacturing Base and Competitors10.10.2 Medical Grade Chitosan Product Category, Application and Specification10.10.3 Zhejiang Fengrun Biotech Medical Grade Chitosan Sales, Revenue, Price and Gross Margin (2015-2020)10.10.4 Main Business Overview10.10.5 Zhejiang Fengrun Biotech Recent Development10.11 Jiangsu Shuanglin10.11.1 Jiangsu Shuanglin Corporation Information10.11.2 Jiangsu Shuanglin Description, Business Overview and Total Revenue10.11.3 Jiangsu Shuanglin Medical Grade Chitosan Sales, Revenue and Gross Margin (2015-2020)10.11.4 Jiangsu Shuanglin Medical Grade Chitosan Products Offered10.11.5 Jiangsu Shuanglin Recent Development10.12 Jiangsu Aoxin Biotechnology10.12.1 Jiangsu Aoxin Biotechnology Corporation Information10.12.2 Jiangsu Aoxin Biotechnology Description, Business Overview and Total Revenue10.12.3 Jiangsu Aoxin Biotechnology Medical Grade Chitosan Sales, Revenue and Gross Margin (2015-2020)10.12.4 Jiangsu Aoxin Biotechnology Medical Grade Chitosan Products Offered10.12.5 Jiangsu Aoxin Biotechnology Recent Development10.13 Qingdao Yunzhou Biochemistry10.13.1 Qingdao Yunzhou Biochemistry Corporation Information10.13.2 Qingdao Yunzhou Biochemistry Description, Business Overview and Total Revenue10.13.3 Qingdao Yunzhou Biochemistry Medical Grade Chitosan Sales, Revenue and Gross Margin (2015-2020)10.13.4 Qingdao Yunzhou Biochemistry Medical Grade Chitosan Products Offered10.13.5 Qingdao Yunzhou Biochemistry Recent Development 11 Medical Grade Chitosan Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis11.1 Medical Grade Chitosan Key Raw Materials11.1.1 Key Raw Materials11.1.2 Key Raw Materials Price11.1.3 Raw Materials Key Suppliers11.2 Manufacturing Cost Structure11.2.1 Raw Materials11.2.2 Labor Cost11.2.3 Manufacturing Expenses11.3 Medical Grade Chitosan Industrial Chain Analysis11.4 Market Opportunities, Challenges, Risks and Influences Factors Analysis11.4.1 Market Opportunities and Drivers11.4.2 Market Challenges11.4.3 Market Risks11.4.4 Porters Five Forces Analysis 12 Market Strategy Analysis, Distributors12.1 Sales Channel12.2 Distributors12.3 Downstream Customers 13 Research Findings and Conclusion 14 Appendix14.1 Methodology/Research Approach14.1.1 Research Programs/Design14.1.2 Market Size Estimation14.1.3 Market Breakdown and Data Triangulation14.2 Data Source14.2.1 Secondary Sources14.2.2 Primary Sources14.3 Author Details14.4 Disclaimer

About Us

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

See the rest here:
Medical Grade Chitosan Market Recent Trends and Developments, by Type, by Product, Regional growth, Profit Margin, Market size, Revenue and Sales over...

Biochemistry

MBA after BCom; subject combo with maths; and scope in biochemistry – The Tribune

Will MBA after Bcom improve my career prospects?

Q. What are my career options if I pursue MCom instead of MBA after completing BCom?

Megha Bisht

A. While an MBA is a professional, job-oriented PG programme in management, an MCom is somewhat more academic & theoretical in content and approach.

After completing your MCom, the main avenues open to you those in Teaching, Accounting & Audit, Taxation, Finance, and Banking.

By adding a BEd to your MCom youll be eligible to teach Commerce at the Plus II level. And if you clear the NET exam, you can even teach at the college level.

MCom graduates can find suitable openings in financial research and analysis, taxation, stock market, insurance, financial planning and advisory, banking, financial services sales in all kinds of financial product and service providers besides those in accounting, financial processing/modeling and documentation as well as in KPOs.

You can sit for general competitive entrance exams such as the Civil Services or State Selection Commission. Your MCom qualification will also allow you to take the selection exams for the Income Tax, Customs and Excise Departments, Comptroller & Auditor General, Bank Probationary Officers.

Which subject combinations are available with maths in Class XI?

Q. I am in Class X. I am confused about choosing a subject next year. I want to pursue maths, but I do not know which other subjects I can take along with it. Can you help me with this?

Arvind Kumar

A. There are three streams in which you can take maths:

Career opportunities are truly wide and varied for anyone who has a talent and passion for mathematics. No wonder its called the queen of sciences!

Whats more, mathematics is not just for mathematicians. The skills you develop while studying for a math degree such as the ability to think logically as well as in abstraction find valuable and multifaceted applications in virtually every walk of life.

Some of the areas where number-crunchers are particularly valued are in: investment banking, insurance companies (Actuaries), taxation, engineering consulting, medical research, bioinformatics, computer science, computer security, data science and Big data, defense, operations research, market research (specifically quantitative) and media planning.

Going places with BSc biochem

Q. I had PCB in Class XII, but I am not very hopeful of clearing the NEET. I am interested in joining BSc biochemistry in DU. Apart from research and lectureship, what other career options can I go for?

Arun Shukla

A. Though personally I think you should give NEET a shot and have a positive attitude about your performance, it is good that you have a plan B in place. And it is a good plan as biochemists are playing an increasingly significant role in biological, environmental and clinical fields, with employment areas stretching from health care to agriculture. Biochemical analysis is used in clinical and forensic science (e.g. DNA fingerprinting) and in the food and pharmaceutical industries. Growth areas, where recruitment is intense, include biotechnology and bioinformatics.

Employment prospects for Biochemists with a master's degree are on the rise. While some go on to pursue research and further study, the rest find employment in industry, Pharma, education and related areas.

Of course, you are free to look at other options in life sciences and healthcare industry or anything else for that matter at the PG level. All the best!

Originally posted here:
MBA after BCom; subject combo with maths; and scope in biochemistry - The Tribune

Biochemistry

Former UT walk-on linebacker recalls juggling band practice, and biochemistry – San Antonio Express-News

AUSTIN Some nights, Shawn Izadi never made it out of the Moncrief-Neuhaus Athletic Center.

Hed pack sheets and pillows, workout gear for the morning training session, and prepare to sleep on a couch inside the complex attached to Royal-Memorial Stadium.

Study sessions for the walk-on linebacker-slash-Longhorn Band saxophonist-slash-biochemistry major might stretch to 1:30 a.m. Those evenings, hed glance at the clock with weary eyes and calculate how much time remained before the morning alarm blared about three and a half hours.

I would just maximize every minute instead of having to walk back home and walk back to Moncrief, Izadi said. I was like, I could save myself 30, 40 minutes, get some sleep and be ready to go in the morning.

By his own admission, Izadi was truly a crazy person.

The Coppell native and 2014 UT graduate didnt originally plan to play football for Mack Brown. Izadi gave up the game as a high school sophomore. Chosen as the bands drum major going into his junior year, he decided to pour his extracurricular efforts into that and abandon a game he still loved.

By spring of his sophomore year, Izadi got an idea. Even with band duties and one of UTs most demanding majors consuming time, he missed the game.

I thought, you know, if Im going to play for any team, it might as well be the best team in the country, Izadi said. The first time I tried out I didnt take myself seriously. I really wasnt prepared from a conditioning standpoint, weight training standpoint. I was just a band nerd at that time. And so of course that ended exactly the way you think its gonna end.

Izadis first tryout was a disaster. The result remains seared into his memory body depleted, corpse-like, crumpled up in a pile of sweat and vomit. Drained of everything save his will to try again.

He went out again the following fall. Better this time, but not enough.

Izadi still hadnt reached his breaking point by the time spring tryouts commenced in 2012. By then, the strength and conditioning staff recognized the face. They could hardly believe the biochem band nerd was back for more punishment.

They were like, Again? Are we gonna have to kill him for a third time? Izadi quipped. And luckily I was in pretty good shape. I wasnt keeling over. And gladly they saw something to take a chance on me.

Still upright and breathing after the third try, Izadi found his name listed among the new walk-ons on a sign posted outside Moncrief. That day felt like a dream.

He floated through the athletic center, in awe of the memorabilia on display, the legends commemorated on plaques and busts. Izadi was part of it now.

I saw my name, and I almost didnt believe it, Izadi confessed. I was like, Is this correct? Because I wasnt expecting I was just naturally you know, keeping my expectations low. This is gonna sound cheesy, but I actually teared up a little bit.

The team gave Izadi a locker next to Jordan Hicks, a high school All-American who went on to win Super Bowl LII as a member of the Philadelphia Eagles. So the saxophonist and future medical student set up shop next to the 2015 NFL draft pick who now plays for the Arizona Cardinals.

About two hours after he was accepted to the Texas football team, Izadi had to scramble to get over to band practice. Somehow, over the next two years, he managed the juggling act.

Izadi suited up for home games and traveled with the band for road trips. He never missed practice for either.

In fact, Brown and the rest of the staff had no idea one of their players was pulling double duty until they traveled to the Cotton Bowl in October 2013 for the Red River Showdown.

We were marching in and Coach Brown looked at me, Izadi recalled. He was like, Is that Shawn? The entire coaching staff is like, Shawn Azadi, whats he doing with a saxophone and a Stetson cowboy hat on?

They just literally went haywire on the sidelines. I think that was actually probably the greatest part for me.

Izadi never appeared in a game. Didnt matter. The experience, the grind and the battle to earn his helmet, was enough.

After graduating he spent a year working at Irvings Abbott Laboratories then returned to football in 2015 as a graduate assistant and coaching intern at North Texas. Brown helped him secure the gig.

All the while, he was waiting on an acceptance letter from University of Texas Rio Grande Valley (UTRGV) School of Medicine.

Its really interesting because looking back it I dont even know if at that time I really had direction, Izadi said. But I knew that I loved football. I knew that I loved medicine. I knew that I wanted to be in one of those fields.

Good news arrived during the season. Izadi enrolled at UTRGV in July 2016 and graduated this spring.

Next week, hell move out to Portland, Ore., to begin training at Oregon Health and Science University for general surgery. It could last five to seven years, two more if Izadi opts to become either a pediatric surgeon or a trauma critical care surgeon.

To most, that sounds like a nightmare. For Izadi, its simply another challenge.

Once I set my mind toward something, Izadi said, Im not going to quit until I get it.

nmoyle@express-news.net

Twitter: @NRmoyle

Go here to see the original:
Former UT walk-on linebacker recalls juggling band practice, and biochemistry - San Antonio Express-News